<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="191">
<accession>P53004</accession>
<accession>A8K747</accession>
<accession>O95019</accession>
<accession>Q86UX0</accession>
<accession>Q96QL4</accession>
<accession>Q9BRW8</accession>
<name>BIEA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Biliverdin reductase A</fullName>
<shortName>BVR A</shortName>
<ecNumber>1.3.1.24</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Biliverdin-IX alpha-reductase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BLVRA</name>
<name type="synonym">BLVR</name>
<name type="synonym">BVR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochim. Biophys. Acta" volume="1309" first="89" last="99">
<title>Cloning and characterization of the cDNA encoding human biliverdin-IX alpha reductase.</title>
<authorList>
<person name="Komuro A."/>
<person name="Tobe T."/>
<person name="Nakano Y."/>
<person name="Yamaguchi T."/>
<person name="Tomita M."/>
</authorList>
<dbReference type="PubMed" id="8950184"/>
<dbReference type="DOI" id="10.1016/s0167-4781(96)00099-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT THR-3</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Eur. J. Biochem." volume="235" first="372" last="381">
<title>Human biliverdin IXalpha reductase is a zinc-metalloprotein. Characterization of purified and Escherichia coli expressed enzymes.</title>
<authorList>
<person name="Maines M.D."/>
<person name="Polevoda B.V."/>
<person name="Huang T.-J."/>
<person name="McCoubrey W.K. Jr."/>
</authorList>
<dbReference type="PubMed" id="8631357"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1996.00372.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS THR-3; VAL-37 AND ARG-56</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT THR-3</scope>
<source>
<tissue>Brain</tissue>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Arch. Biochem. Biophys." volume="300" first="320" last="326">
<title>Purification and characterization of human biliverdin reductase.</title>
<authorList>
<person name="Maines M.D."/>
<person name="Trakshel G.M."/>
</authorList>
<dbReference type="PubMed" id="8424666"/>
<dbReference type="DOI" id="10.1006/abbi.1993.1044"/>
</citation>
<scope>PROTEIN SEQUENCE OF 3-36; 48-74 AND 228-248</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="24343" last="24348">
<title>Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from human liver. Purification and characterization.</title>
<authorList>
<person name="Yamaguchi T."/>
<person name="Komoda Y."/>
<person name="Nakajima H."/>
</authorList>
<dbReference type="PubMed" id="7929092"/>
</citation>
<scope>PROTEIN SEQUENCE OF 3-22</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Liver Int." volume="29" first="1116" last="1124">
<title>A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice).</title>
<authorList>
<person name="Gafvels M."/>
<person name="Holmstrom P."/>
<person name="Somell A."/>
<person name="Sjovall F."/>
<person name="Svensson J.O."/>
<person name="Stahle L."/>
<person name="Broome U."/>
<person name="Stal P."/>
</authorList>
<dbReference type="PubMed" id="19580635"/>
<dbReference type="DOI" id="10.1111/j.1478-3231.2009.02029.x"/>
</citation>
<scope>INVOLVEMENT IN HBLVD</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174 AND SER-178</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-248 AND LYS-253</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Crystal structure of human biliverdin reductase A.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 7-296 IN COMPLEX WITH NADP</scope>
</reference>
<comment type="function">
<text>Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IX alpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>bilirubin IXalpha + NAD(+) = biliverdin IXalpha + H(+) + NADH</text>
<dbReference type="Rhea" id="RHEA:15797"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57945"/>
<dbReference type="ChEBI" id="CHEBI:57977"/>
<dbReference type="ChEBI" id="CHEBI:57991"/>
<dbReference type="EC" id="1.3.1.24"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction>
<text>bilirubin IXalpha + NADP(+) = biliverdin IXalpha + H(+) + NADPH</text>
<dbReference type="Rhea" id="RHEA:15793"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57783"/>
<dbReference type="ChEBI" id="CHEBI:57977"/>
<dbReference type="ChEBI" id="CHEBI:57991"/>
<dbReference type="ChEBI" id="CHEBI:58349"/>
<dbReference type="EC" id="1.3.1.24"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor>
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text>Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="pathway">
<text>Porphyrin-containing compound metabolism; protoheme degradation.</text>
</comment>
<comment type="subunit">
<text evidence="12">Monomer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7410441">
<id>P53004</id>
</interactant>
<interactant intactId="EBI-739832">
<id>Q8TBB1</id>
<label>LNX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7410441">
<id>P53004</id>
</interactant>
<interactant intactId="EBI-959949">
<id>P28482</id>
<label>MAPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Liver.</text>
</comment>
<comment type="disease" evidence="7">
<disease id="DI-03209">
<name>Hyperbiliverdinemia</name>
<acronym>HBLVD</acronym>
<description>A condition characterized by a green discoloration of the skin, urine, serum, and other bodily fluids. It is due to increased biliverdin resulting from inefficient conversion to bilirubin. Affected individuals appear to have symptoms only in the context of obstructive cholestasis and/or liver failure. In some cases, green jaundice can resolve after resolution of obstructive cholestasis.</description>
<dbReference type="MIM" id="614156"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Uses the reactants NADH or NADPH depending on the pH; NADH is used at the acidic pH range (6-6.9) and NADPH at the alkaline range (8.5-8.7). NADPH, however, is the probable reactant in biological systems.</text>
</comment>
<comment type="similarity">
<text evidence="14">Belongs to the Gfo/Idh/MocA family. Biliverdin reductase subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/blvra/"/>
</comment>
<dbReference type="EC" id="1.3.1.24"/>
<dbReference type="EMBL" id="U34877">
<property type="protein sequence ID" value="AAC35588.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X93086">
<property type="protein sequence ID" value="CAA63635.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291862">
<property type="protein sequence ID" value="BAF84551.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY616754">
<property type="protein sequence ID" value="AAT11126.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005189">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004939">
<property type="protein sequence ID" value="AAD05025.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004985">
<property type="protein sequence ID" value="AAP21879.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005902">
<property type="protein sequence ID" value="AAH05902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008456">
<property type="protein sequence ID" value="AAH08456.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5472.1"/>
<dbReference type="PIR" id="G02066">
<property type="entry name" value="G02066"/>
</dbReference>
<dbReference type="PIR" id="S62624">
<property type="entry name" value="S62624"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000703.2">
<property type="nucleotide sequence ID" value="NM_000712.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001240752.1">
<property type="nucleotide sequence ID" value="NM_001253823.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011513776.1">
<property type="nucleotide sequence ID" value="XM_011515474.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016868009.1">
<property type="nucleotide sequence ID" value="XM_017012520.1"/>
</dbReference>
<dbReference type="PDB" id="2H63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=7-296"/>
</dbReference>
<dbReference type="PDBsum" id="2H63"/>
<dbReference type="SMR" id="P53004"/>
<dbReference type="BioGRID" id="107113">
<property type="interactions" value="37"/>
</dbReference>
<dbReference type="CORUM" id="P53004"/>
<dbReference type="DIP" id="DIP-42180N"/>
<dbReference type="IntAct" id="P53004">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="P53004"/>
<dbReference type="STRING" id="9606.ENSP00000385757"/>
<dbReference type="DrugBank" id="DB00157">
<property type="generic name" value="NADH"/>
</dbReference>
<dbReference type="iPTMnet" id="P53004"/>
<dbReference type="MetOSite" id="P53004"/>
<dbReference type="PhosphoSitePlus" id="P53004"/>
<dbReference type="SwissPalm" id="P53004"/>
<dbReference type="BioMuta" id="BLVRA"/>
<dbReference type="DMDM" id="23830892"/>
<dbReference type="OGP" id="P53004"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00294158"/>
<dbReference type="EPD" id="P53004"/>
<dbReference type="jPOST" id="P53004"/>
<dbReference type="MassIVE" id="P53004"/>
<dbReference type="MaxQB" id="P53004"/>
<dbReference type="PaxDb" id="P53004"/>
<dbReference type="PeptideAtlas" id="P53004"/>
<dbReference type="PRIDE" id="P53004"/>
<dbReference type="ProteomicsDB" id="56566"/>
<dbReference type="Antibodypedia" id="13185">
<property type="antibodies" value="336 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000265523">
<property type="protein sequence ID" value="ENSP00000265523"/>
<property type="gene ID" value="ENSG00000106605"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000402924">
<property type="protein sequence ID" value="ENSP00000385757"/>
<property type="gene ID" value="ENSG00000106605"/>
</dbReference>
<dbReference type="GeneID" id="644"/>
<dbReference type="KEGG" id="hsa:644"/>
<dbReference type="UCSC" id="uc003tir.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="644"/>
<dbReference type="DisGeNET" id="644"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000106605.10"/>
<dbReference type="GeneCards" id="BLVRA"/>
<dbReference type="HGNC" id="HGNC:1062">
<property type="gene designation" value="BLVRA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000106605">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="BLVRA"/>
<dbReference type="MIM" id="109750">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614156">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P53004"/>
<dbReference type="OpenTargets" id="ENSG00000106605"/>
<dbReference type="Orphanet" id="276405">
<property type="disease" value="Hyperbiliverdinemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25373"/>
<dbReference type="eggNOG" id="ENOG502QTSZ">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000011072"/>
<dbReference type="HOGENOM" id="CLU_053157_0_0_1"/>
<dbReference type="InParanoid" id="P53004"/>
<dbReference type="KO" id="K00214"/>
<dbReference type="OMA" id="NMPNVGV"/>
<dbReference type="OrthoDB" id="879838at2759"/>
<dbReference type="PhylomeDB" id="P53004"/>
<dbReference type="TreeFam" id="TF342889"/>
<dbReference type="BioCyc" id="MetaCyc:HS02928-MONOMER"/>
<dbReference type="BRENDA" id="1.3.1.24">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P53004"/>
<dbReference type="Reactome" id="R-HSA-189483">
<property type="pathway name" value="Heme degradation"/>
</dbReference>
<dbReference type="SIGNOR" id="P53004"/>
<dbReference type="UniPathway" id="UPA00684"/>
<dbReference type="BioGRID-ORCS" id="644">
<property type="hits" value="2 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="BLVRA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P53004"/>
<dbReference type="GenomeRNAi" id="644"/>
<dbReference type="Pharos" id="P53004">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P53004"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="RNAct" id="P53004">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000106605">
<property type="expression patterns" value="Expressed in monocyte and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P53004">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P53004">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004074">
<property type="term" value="F:biliverdin reductase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0042167">
<property type="term" value="P:heme catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055114">
<property type="term" value="P:oxidation-reduction process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR017094">
<property type="entry name" value="Biliverdin_Rdtase_A"/>
</dbReference>
<dbReference type="InterPro" id="IPR015249">
<property type="entry name" value="Biliverdin_Rdtase_cat"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000683">
<property type="entry name" value="Oxidoreductase_N"/>
</dbReference>
<dbReference type="Pfam" id="PF09166">
<property type="entry name" value="Biliv-reduc_cat"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01408">
<property type="entry name" value="GFO_IDH_MocA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037032">
<property type="entry name" value="Biliverdin_reductase_A"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="propeptide" id="PRO_0000010852" evidence="8 9">
<location>
<begin position="1"/>
<end position="2"/>
</location>
</feature>
<feature type="chain" description="Biliverdin reductase A" id="PRO_0000010853" evidence="10">
<location>
<begin position="3"/>
<end position="296"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD or NADP">
<location>
<begin position="15"/>
<end position="20"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD or NADP">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD or NADP">
<location>
<begin position="77"/>
<end position="80"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Val">
<location>
<begin position="11"/>
<end position="16"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="5">
<location>
<position position="280"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="5">
<location>
<position position="281"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="5">
<location>
<position position="292"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="5">
<location>
<position position="293"/>
</location>
</feature>
<feature type="binding site" description="NAD or NADP; via carbonyl oxygen">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="174"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="178"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="230"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs699512." id="VAR_019230" evidence="6 11 13">
<original>A</original>
<variation>T</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17245918." id="VAR_019231" evidence="13">
<original>L</original>
<variation>V</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1050916." id="VAR_014851" evidence="13">
<original>Q</original>
<variation>R</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH05902." ref="6" evidence="14">
<original>L</original>
<variation>S</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA63635." ref="2" evidence="14">
<original>AG</original>
<variation>SD</variation>
<location>
<begin position="154"/>
<end position="155"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA63635." ref="2" evidence="14">
<original>E</original>
<variation>D</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="9"/>
<end position="14"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="18"/>
<end position="28"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="33"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="59"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="77"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="104"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="121"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="129"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="131"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="145"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="165"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="170"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="182"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="198"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="212"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="226"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="250"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="268"/>
<end position="290"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2H63"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19580635"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7929092"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8424666"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8631357"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8950184"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source ref="18"/>
</evidence>
<evidence key="13" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="14" type="ECO:0000305"/>
<sequence length="296" mass="33428" checksum="2CF2AA7F1CDDB707" modified="2002-10-10" version="2" precursor="true">MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGSIDGVQQISLEDALSSQEVEVAYICSESSSHEDYIRQFLNAGKHVLVEYPMTLSLAAAQELWELAEQKGKVLHEEHVELLMEEFAFLKKEVVGKDLLKGSLLFTAGPLEEERFGFPAFSGISRLTWLVSLFGELSLVSATLEERKEDQYMKMTVCLETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLENVPNVGVNKNIFLKDQNIFVQKLLGQFSEKELAAEKKRILHCLGLAEEIQKYCCSRK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

